Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $100K | — |
| Operating income | — | -$1.27M | -$1.51M | -$4.50M | -$27.7M |
| Operating margin | — | — | — | -4500.0% | — |
| Net income | — | $7.17M | $1.16M | -$9.23M | -$35.8M |
| Net margin | — | — | — | -9230.0% | — |
| EPS (diluted) | — | $0.30 | $0.12 | -$357.14 | -$107.01 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | — | -$581K | -$2.06M | -$2.07M | -$16.2M |
| Capital expenditures | — | — | — | — | $8.00K |
| Free cash flow | — | — | — | — | -$16.3M |
| Share buybacks | — | — | $185M | $3.25M | — |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $741K | $193K | $4.52K | $191K | $1.78M |
| Total assets | $193M | $195M | $10.9M | $3.07M | $3.77M |
| Total liabilities | $7.32M | $1.83M | $5.09M | $57.1M | $30.4M |
| Shareholders' equity | -$5.91M | -$619K | -$110M | -$119M | -$26.7M |
| Retained earnings | -$5.91M | -$620K | -$3.46M | -$125M | -$161M |
| Shares (wtd avg diluted) | 5.19M | 5.19M | 5.19M | 25.8B | 335K |
Every figure is extracted from Profusa, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.